1887

Abstract

Herpesvirus late genes require viral DNA replication for maximal expression. Although late gene expression appears to require DNA replication in alphaherpesviruses, studies in Epstein–Barr virus (EBV) suggest that this -requirement might not pertain to the gammaherpesviruses. Based on these findings, a system was created to investigate the elements required for the regulation of Kaposi’s sarcoma-associated herpesvirus (KSHV; human herpesvirus-8) late gene expression. The transcript of a classic late gene encoding the viral assembly protein was characterized and reporter genes driven by the assembly protein promoter region were constructed. Unlike the EBV case, expression of a reporter gene under the control of the assembly protein promoter did not display authentic regulation when removed from the context of the viral genome. Although reporter expression rose in cells displaying lytic replication, this expression was not diminished by specific inhibitors of viral DNA synthesis. Minimal core promoters were similarly unable to reproduce late gene regulation. These results suggest that proper KSHV late gene expression is likely to be dependent upon virus lytic replication and indicate that the regulation of KSHV late genes more closely resembles that observed in herpes simplex virus than that described for EBV.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-8-2039
2000-08-01
2019-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/8/0812039a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-8-2039&mimeType=html&fmt=ahah

References

  1. Ambroziak, J. A., Blackbourn, D. J., Herndier, B. G., Glogau, R. G., Gullett, J. H., McDonald, A. R., Lennette, E. T. & Levy, J. A. ( 1995; ). Herpes-like sequences in HIV-infected and uninfected Kaposi’s sarcoma patients. Science 268, 582-583.[CrossRef]
    [Google Scholar]
  2. Beral, V., Peterman, T. A., Berkelman, R. L. & Jaffe, H. W. ( 1990; ). Kaposi’s sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335, 123-128.[CrossRef]
    [Google Scholar]
  3. Boshoff, C. & Weiss, R. A. ( 1998; ). Kaposi’s sarcoma-associated herpesvirus. Advances in Cancer Research 75, 57-86.
    [Google Scholar]
  4. Cesarman, E., Chang, Y., Moore, P. S., Said, J. W. & Knowles, D. M. ( 1995a; ). Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. New England Journal of Medicine 332, 1186-1191.[CrossRef]
    [Google Scholar]
  5. Cesarman, E., Moore, P. S., Rao, P. H., Inghirami, G., Knowles, D. M. & Chang, Y. ( 1995b; ). In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi’s sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86, 2708-2714.
    [Google Scholar]
  6. Dennis, D. & Smiley, J. R. ( 1984; ). Transactivation of a late herpes simplex virus promoter. Molecular and Cellular Biology 4, 544-551.
    [Google Scholar]
  7. Flanagan, W. M., Papavassiliou, A. G., Rice, M., Hecht, L. B., Silverstein, S. & Wagner, E. K. ( 1991; ). Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly. Journal of Virology 65, 769-786.
    [Google Scholar]
  8. Foreman, K. E., Friborg, J.Jr, Kong, W. P., Woffendin, C., Polverini, P. J., Nickoloff, B. J. & Nabel, G. J. ( 1997; ). Propagation of a human herpesvirus from AIDS-associated Kaposi’s sarcoma. New England Journal of Medicine 336, 163-171.[CrossRef]
    [Google Scholar]
  9. Gao, S. J., Kingsley, L., Hoover, D. R., Spira, T. J., Rinaldo, C. R., Saah, A., Phair, J., Detels, R., Parry, P., Chang, Y. & Moore, P. S. ( 1996a; ). Seroconversion to antibodies against Kaposi’s sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi’s sarcoma. New England Journal of Medicine 335, 233-241.[CrossRef]
    [Google Scholar]
  10. Gao, S. J., Kingsley, L., Li, M., Zheng, W., Parravicini, C., Ziegler, J., Newton, R., Rinaldo, C. R., Saah, A., Phair, J., Detels, R., Chang, Y. & Moore, P. S. ( 1996b; ). KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi’s sarcoma. Nature Medicine 2, 925-928.[CrossRef]
    [Google Scholar]
  11. Homa, F. L., Otal, T. M., Glorioso, J. C. & Levine, M. ( 1986; ). Transcriptional control signals of a herpes simplex virus type 1 late (γ2) gene lie within bases −34 to +124 relative to the 5′ terminus of the mRNA. Molecular and Cellular Biology 6, 3652-3666.
    [Google Scholar]
  12. Homa, F. L., Glorioso, J. C. & Levine, M. ( 1988; ). A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene. Genes & Development 2, 40-53.[CrossRef]
    [Google Scholar]
  13. Honess, R. W. & Roizman, B. ( 1974; ). Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. Journal of Virology 14, 8-19.
    [Google Scholar]
  14. Johnson, P. A. & Everett, R. D. ( 1986a; ). DNA replication is required for abundant expression of a plasmid-borne late US11 gene of herpes simplex virus type 1. Nucleic Acids Research 14, 3609-3625.[CrossRef]
    [Google Scholar]
  15. Johnson, P. A. & Everett, R. D. ( 1986b; ). The control of herpes simplex virus type-1 late gene transcription: a ‘TATA-box’/cap site region is sufficient for fully efficient regulated activity. Nucleic Acids Research 14, 8247-8264.[CrossRef]
    [Google Scholar]
  16. Kedes, D. H., Operskalski, E., Busch, M., Kohn, R., Flood, J. & Ganem, D. ( 1996; ). The seroepidemiology of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nature Medicine 2, 918-924.[CrossRef]
    [Google Scholar]
  17. Kibler, P. K., Duncan, J., Keith, B. D., Hupel, T. & Smiley, J. R. ( 1991; ). Regulation of herpes simplex virus true late gene expression: sequences downstream from the US11 TATA box inhibit expression from an unreplicated template. Journal of Virology 65, 6749-6760.
    [Google Scholar]
  18. Lin, S. F., Sun, R., Heston, L., Gradoville, L., Shedd, D., Haglund, K., Rigsby, M. & Miller, G. ( 1997; ). Identification, expression, and immunogenicity of Kaposi’s sarcoma-associated herpesvirus-encoded small viral capsid antigen. Journal of Virology 71, 3069-3076.
    [Google Scholar]
  19. Lukac, D. M., Renne, R., Kirshner, J. R. & Ganem, D. ( 1998; ). Reactivation of Kaposi’s sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 252, 304-312.[CrossRef]
    [Google Scholar]
  20. Lukac, D. M., Kirshner, J. R. & Ganem, D. ( 1999; ). Transcriptional activation by the product of open reading frame 50 of Kaposi’s sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. Journal of Virology 73, 9348-9361.
    [Google Scholar]
  21. Martin, J. N., Ganem, D. E., Osmond, D. H., Page-Shafer, K. A., Macrae, D. & Kedes, D. H. ( 1998; ). Sexual transmission and the natural history of human herpesvirus 8 infection. New England Journal of Medicine 338, 948-954.[CrossRef]
    [Google Scholar]
  22. Mavromara-Nazos, P. & Roizman, B. ( 1987; ). Activation of herpes simplex virus 1 γ2 genes by viral DNA replication. Virology 161, 593-598.[CrossRef]
    [Google Scholar]
  23. Mavromara-Nazos, P. & Roizman, B. ( 1989; ). Delineation of regulatory domains of early (β) and late (γ2) genes by construction of chimeric genes expressed in herpes simplex virus 1 genomes. Proceedings of the National Academy of Sciences, USA 86, 4071-4075.[CrossRef]
    [Google Scholar]
  24. Mesri, E. A., Cesarman, E., Arvanitakis, L., Rafii, S., Moore, M. A., Posnett, D. N., Knowles, D. M. & Asch, A. S. ( 1996; ). Human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus is a new transmissible virus that infects B cells. Journal of Experimental Medicine 183, 2385-2390.[CrossRef]
    [Google Scholar]
  25. Miller, G., Heston, L., Grogan, E., Gradoville, L., Rigsby, M., Sun, R., Shedd, D., Kushnaryov, V. M., Grossberg, S. & Chang, Y. ( 1997; ). Selective switch between latency and lytic replication of Kaposi’s sarcoma herpesvirus and Epstein–Barr virus in dually infected body cavity lymphoma cells. Journal of Virology 71, 314-324.
    [Google Scholar]
  26. Moore, P. S. & Chang, Y. ( 1995; ). Detection of herpesvirus-like DNA sequences in Kaposi’s sarcoma in patients with and without HIV infection. New England Journal of Medicine 332, 1181-1185.[CrossRef]
    [Google Scholar]
  27. Moore, P. S., Gao, S. J., Dominguez, G., Cesarman, E., Lungu, O., Knowles, D. M., Garber, R., Pellett, P. E., McGeoch, D. J. & Chang, Y. ( 1996a; ). Primary characterization of a herpesvirus agent associated with Kaposi’s sarcomae. Journal of Virology 70, 549-558.
    [Google Scholar]
  28. Moore, P. S., Kingsley, L. A., Holmberg, S. D., Spira, T., Gupta, P., Hoover, D. R., Parry, J. P., Conley, L. J., Jaffe, H. W. & Chang, Y. ( 1996b; ). Kaposi’s sarcoma-associated herpesvirus infection prior to onset of Kaposi’s sarcoma. AIDS 10, 175-180.[CrossRef]
    [Google Scholar]
  29. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. & Ganem, D. ( 1996; ). Lytic growth of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Medicine 2, 342-346.[CrossRef]
    [Google Scholar]
  30. Renne, R., Blackbourn, D., Whitby, D., Levy, J. & Ganem, D. ( 1998; ). Limited transmission of Kaposi’s sarcoma-associated herpesvirus in cultured cells. Journal of Virology 72, 5182-5188.
    [Google Scholar]
  31. Russo, J. J., Bohenzky, R. A., Chien, M. C., Chen, J., Yan, M., Maddalena, D., Parry, J. P., Peruzzi, D., Edelman, I. S., Chang, Y. & Moore, P. S. ( 1996; ). Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proceedings of the National Academy of Sciences, USA 93, 14862-14867.[CrossRef]
    [Google Scholar]
  32. Serio, T. R., Kolman, J. L. & Miller, G. ( 1997; ). Late gene expression from the Epstein–Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis. Journal of Virology 71, 8726-8734.
    [Google Scholar]
  33. Serio, T. R., Cahill, N., Prout, M. E. & Miller, G. ( 1998; ). A functionally distinct TATA box required for late progression through the Epstein–Barr virus life cycle. Journal of Virology 72, 8338-8343.
    [Google Scholar]
  34. Silver, S. & Roizman, B. ( 1985; ). γ2–Thymidine kinase chimeras are identically transcribed but regulated as γ2 genes in herpes simplex virus genomes and as β genes in cell genomes. Molecular and Cellular Biology 5, 518-528.
    [Google Scholar]
  35. Soulier, J., Grollet, L., Oksenhendler, E., Cacoub, P., Cazals-Hatem, D., Babinet, P., d’Agay, M. F., Clauvel, J. P., Raphael, M., Degos, L. & Sigaux, F. ( 1995; ). Kaposi’s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman’s disease. Blood 86, 1276-1280.
    [Google Scholar]
  36. Steffy, K. R. & Weir, J. P. ( 1991; ). Upstream promoter elements of the herpes simplex virus type 1 glycoprotein H gene. Journal of Virology 65, 972-975.
    [Google Scholar]
  37. Sun, R., Lin, S. F., Gradoville, L., Yuan, Y., Zhu, F. & Miller, G. ( 1998; ). A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus. Proceedings of the National Academy of Sciences, USA 95, 10866-10871.[CrossRef]
    [Google Scholar]
  38. Sun, R., Lin, S.-F., Staskus, K., Gradoville, L., Grogan, E., Haase, A. & Miller, G. ( 1999; ). Kinetics of Kaposi’s sarcoma-associated herpesvirus gene expression. Journal of Virology 73, 2232-2242.
    [Google Scholar]
  39. Unal, A., Pray, T. R., Lagunoff, M., Pennington, M. W., Ganem, D. & Craik, C. S. ( 1997; ). The protease and the assembly protein of Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8). Journal of Virology 71, 7030-7038.
    [Google Scholar]
  40. Whitby, D., Howard, M. R., Tenant-Flowers, M., Brink, N. S., Copas, A., Boshoff, C., Hatzioannou, T., Suggett, F. E., Aldam, D. M., Denton, A. S., Miller, R. F., Weller, I. V. D., Weiss, R. A. & Schulz, T. F. ( 1995; ). Detection of Kaposi sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi’s sarcoma. Lancet 346, 799-802.[CrossRef]
    [Google Scholar]
  41. Zhong, W., Wang, H., Herndier, B. & Ganem, D. ( 1996; ). Restricted expression of Kaposi’s sarcoma-associated herpesvirus genes in Kaposi’s sarcoma. Proceedings of the National Academy of Sciences, USA 93, 6641-6646.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-8-2039
Loading
/content/journal/jgv/10.1099/0022-1317-81-8-2039
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error